Capsule
SHUNASIMINE CAP
Summary
SHUNASIMINE CAP — Capsule containing caffeine, diprophylline, guaifenesin, pentoxyverine citrate. Hong Kong Registration No. HK-56510. Certificate Holder: SYNCO (H.K.) LIMITED. Date of Registration: 18 Apr, 2008.
Product NameSHUNASIMINE CAP
Registration No.HK-56510
Certificate HolderSYNCO (H.K.) LIMITED
Holder Address7, DAI SHUN STREET, TAI PO IND EST, TAI PO, NEW TERRITORIES
Ingredientscaffeine, diprophylline, guaifenesin, pentoxyverine citrate
Dosage FormCapsule
Legal ClassificationPart 1 Poison
Sale RequirementPharmacy only Medicines
Date of Registration18 Apr, 2008
ATC codesD11AX26, N06BC01, R03DA01, R05CA03, R05DB05
ATC Classification
ATC level 1
D Dermatologicals / N Nervous System / R Respiratory System
All ATC groupsD11, N06, R03, R05
This product contains more than one active ingredient. The ATC groups above describe the ingredients, not a single category for the product as a whole.
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。